| Literature DB >> 33768172 |
J Vini Mary Antony1, Pratibha Ramani1, Abilasha Ramasubramanian1, Gheena Sukumaran1.
Abstract
Utilization of tobacco products is a global epidemic that causes a health threat among the adolescents and adults of the world. If the current pattern perpetuates, it is estimated to cause 10 million deaths each year by 2020. According to the 2009-2010 survey by Global Adult Tobacco Survey, 53.5% of Indians use tobacco products (66.2% of men and 40% of women). Cancers of the lip and oral cavity are highly frequent in Southern Asia (eg: India and Sri Lanka) and it is also the leading cause of cancer death among men in India and Sri Lanka. AIM ANDEntities:
Keywords: Egg shell membrane; Khaini; Oral cancer; Tobacco; Tobacco particle size penetration& proliferation; potentially malignant disorders
Year: 2021 PMID: 33768172 PMCID: PMC7980078 DOI: 10.1016/j.heliyon.2021.e06455
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Figure 1.1Lower magnification (×300) of Beedi exposed to egg shell membrane showing aggregates of tobacco particles scattered among the meshwork.
Figure 1.2At 1200 x -Beedi exposed to egg shell membrane showing aggregates of tobacco particles scattered among the meshwork.
Figure 1.3Higher magnification (×5000) of beedi exposed egg shell membrane showing clumps of tobacco particles adherent to the meshwork along with disruption of the collagen meshwork.
Figure 1.4Lower magnification (×300) of Gutka exposed to egg shell membrane showing aggregates of tobacco particles scattered among the meshwork.
Figure 1.5At 1200 x -Gutka exposed to egg shell membrane showing aggregates of tobacco particles scattered among the meshwork.
Figure 1.6Higher magnification (×5000) of Gutka exposed to egg shell membrane showing clumps of tobacco particles adherent to the meshwork along with disruption of the collagen meshwork.
Figure 1.7Lower magnification (×300) of Khaini exposed to egg shell membrane showing aggregates of tobacco particles scattered among the meshwork.
Figure 1.8At 1200 x -Khaini exposed to egg shell membrane showing aggregates of tobacco particles scattered among the meshwork.
Figure 1.9Higher magnification (×5000) of Khaini exposed egg shell membrane showing clumps of tobacco particles adherent to the meshwork along with disruption of the collagen meshwork.
Figure 1.10Lower magnification (×300) of Cigarette exposed to egg shell membrane showing aggregates of tobacco particles scattered among the meshwork.
Figure 1.11At 1200 x -Cigarette exposed to egg shell membrane showing aggregates of tobacco particles scattered among the meshwork.
Figure 1.12Higher magnification (×5000) of Cigarette exposed egg shell membrane showing clumps of tobacco particles adherent to the meshwork along with disruption of the collagen meshwork.
Particle size analysis of tobacco products using high resolution scanning electron microscope.
| SAMPLES | Mean(mm) | SD(mm) | |
|---|---|---|---|
| BEEDI | Length | 10.51 | 0.44 |
| Width | 9.36 | 0.57 | |
| GUTKA | Length | 6.89 | 0.57 |
| Width | 5.77 | 0.33 | |
| KHAINI | Length | 4.85 | 0.53 |
| Width | 3.80 | 0.28 | |
| CIGARETTE | Length | 9.35 | 0.74 |
| Width | 7.86 | 0.32 |
Comparison of means of particle size (length and width) of tobacco particles between groups using ANOVA.
| Particle-size | Sum of Squares | Df | Mean Square | F-Value | p-Value | |
|---|---|---|---|---|---|---|
| Particle-size: Length | Between Groups | .323 | 2 | 0.162 | 0.024 | 0.976 |
| Within Groups | 60.097 | 9 | 6.677 | |||
| Total | 60.420 | 11 | ||||
| Particle-size: Width | Between Groups | .359 | 2 | 0.179 | 0.030 | 0.971 |
| Within Groups | 54.130 | 9 | 6.014 | |||
| Total | 54.489 | 11 | ||||
Determination of penetration rate of the tobacco products on egg shell membrane using spectroflurometer.
| S.NO | SAMPLE NAME | Penetration rate on egg shell membrane ACRIDINE ORANGE UNITS (×10-3/ML) | Penetration rate on cell line ACRIDINE ORANGE UNITS (×10-3/ml) |
|---|---|---|---|
| 1. | ESM 1-Beedi | 23.05 | 2.187 |
| 2. | ESM-2-Gutka | 25.86 | 2.388 |
| 3. | ESM 3-Khaini | 27.45 | 2.534 |
| 4. | ESM 4-Cigarette | 17.32 | 1.364 |
| 5. | ESM C-Control | 0.69 | 0.058 |
Figure 2.1Control cell lines.
Figure 2.2At 300 μg/mL of Beedi concentration the cells showed the above proliferative activity.
Figure 2.3At 300 μg/mL of Gutka concentration the cells showed the above proliferative activity.
Figure 2.4At 300 μg/mL of Khaini concentration the cells showed the above proliferative activity.
Figure 2.5At 300 μg/mL of Cigarette concentration the cells showed the above proliferative activity.
Figure 3Depicts the overall proliferative activity of the tobacco samples with Khaini showing an increased rate of proliferative activity among all the tobacco products.
Constituent analysis of cigarette, beedi, khaini and gutka using GC-MS.
| S.NO | CIGARETTE | CONCENTRATION | KHAINI | CONCENTRATION | GUTKA | CONCENTRATION | BEEDI | CONCENTRATION |
|---|---|---|---|---|---|---|---|---|
| 1. | N,N-Dimethylforma mide ethylene acetal | 0.03 | Benzyloxyacetaldehyde dimethyl acetal | 10.02 | Pyrrol-2(5H)-one, 4-acetyl-5-(2,4-dichloro phenyl)-1-(2-furfuryl) | 0.26 | Ethyl aminomethylformimidate | 0.63 |
| 2. | l-Cysteine, N,S-bis(m-toluoyl)-, methyl ester | 0.16 | Paredrine | 0.09 | 3,5-Dimethoxycinnamic acid, tert-butyldimethylsilyl ester | 0.36 | N-Methyladrenaline | 1.2 |
| 3. | (3H)-Isobenzofuran one, 3-[(3,5-dimethylph enyl)amine | 0.41 | Dimethyl hydrastate | 8.22 | 1-Tripropylsilyloxy-3-ph enylpropane | 1.06 | Epinephrine | 1.66 |
| 4. | Cinnamic acid | 0.47 | o-Methylisourea hydrogen sulfate | 6.45 | N,N-Dimethyl-4-nitroso- 3-(trimethylsilyl)aniline | 0.81 | Methylmandelic acid | 1.56 |
| 5. | Pyridine-3-carboxy lic acid, 1,4-dihydro-5-cyan o-2-hydr 4o3x1y9-45-4(4-isopr o1p.1y7lp henol) | 1.17 | Acetamide, 2-chloro-N | 11.6 | Homogentisic acid | 0.67 | Chloroaniline-5-sulfonic acid | 1.21 |
| 6. | (3H)-Isobenzofuran one, 3-[(3,5-dimethylph enyl)amino 1]5 | 0.43 | Acridine-9-carbaldehy de | 0.35 | Hexestrol di-TMS | 0.86 | 3-Phenyl-2H-chromene | 20.96 |
| 7. | Anthranilic acid | 1.37 | 5-(p-Aminophenyl)-4-(p-tolyl)-2-thiazolamine | 5.44 | Benzo[h]quinoline, 2,4-dimethyl-2,4-Dimethylbenzene< | 20.07 | N-Methyl nicotinimide | 31.91 |
| 8. | Phosphonic acid | 1.98 | Morphinan, | 0.59 | trans-4′-Ethyl-4-(methyl thio)chalcone | 9.43 | 2-Bromo-4,5-dimethoxyc innamic acid | 13.17 |
| 9. | Phosphonic acid 2- | 2.49 | 3-Butoxy-1,1,1,7,7,7-he xamethyl-3,5,5-tris(tri methylsiloxane) | 0.73 | Silicic acid | 13.33 | ||
| 10. | 4-(4-methoxyphenyl)-2- m e1t2h3y0l-54 | 27.53 | ||||||
| 11. | 3-Phenyl-2H-chrom ene | 22.09 | Acridine-9-carbaldehy de | 0.67 | ||||
| 12. | 2′,4′-Dihydroxyacetophe none, bis(trimethylsilyl) etherE | 11.03 | Benzo[f][1,4]oxazepin-3- one, | 0.05 | ||||
| 13. | 2H-1,3,4-Benzotria zepine-2-thione, | |||||||
| 14. | 5-benzyl-1,3-dihyd ro | |||||||
| 15. | 1,3,4-benzotriazepi ne-2- | 15.34 | ||||||
| 16. | 1,2-Benzisothiazol-3-a mine | 21.21 | Ethylphosphonic acid, bis(tert-butyldimethyles ter | 37.64 | Cyclobarbital | 0.09 | ||
| 17. | 4-Quinolinecarboxy lic acid | 6.22 | Isophthalic | acid, di(2-methoxyethyl) ester | 1.01 | diethyl bis(trimethylsilyl) ester | 0.34 | 3-Amino-4-chlorobenzen esulfonic acid |